Key factors influencing dose selection include: Treatment goals : Whether the primary aim is glycaemic control, weight reduction, or cardiovascular risk reduction Baseline HbA1c and blood glucose levels : Higher values may eventually require higher maintenance doses Body weight and BMI : Particularly relevant for weight management indications Renal function : Most GLP-1 medications (semaglutide, liraglutide, dulaglutide) do not require dose adjustment for kidney impairment, but exenatide and lixisenatide should be used with caution or avoided in severe renal impairment Concurrent medications : Especially other glucose-lowering agents that might increase hypoglycaemia risk Previous medication tolerance : History of gastrointestinal sensitivity influences titration speed Cardiovascular history : Some GLP-1 medications have proven cardiovascular benefits at specific doses Diabetic retinopathy status : Rapid improvement in blood glucose can temporarily worsen retinopathy, particularly with semaglutide [22] [23] Your doctor will typically schedule regular follow-up appointments during the initial months of treatment
This also feels like a good time to remind you that retatrutide isnt approved yet, which means that a clinician cant prescribe it to you
As depicted in the figure below, these patients were directed to administer 5 units from a vial
GLP1 comes in single-use, pre-filled syringes
As your body adjusts, your healthcare provider at Set Point Medical Weight Loss Clinic will closely monitor your progress, ensuring that any side effects are manageable and that you are moving toward your weight loss goals safely
